VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce that its Health Canada Drug Establishment Licence (DEL) has been amended following a comprehensive Good Manufacturing Practices (GMP) inspection of its Kelowna, British Columbia Facility. Under the amended licence, issued by Health ...